metformin after semaglutide Photos by Apothecademy (@apothecademy) · May 13, 2026 Dr. Charles Mok discusses the

in Diabetes, Obesity and Metabolism in early 2026 (the Wiley DOM TRIUMPH design paper), and the individual trial identifiers are public on ClinicalTrials.gov

October 12, 2022

These drugs may also be useful for preventing and treating several other conditions, including: Type 2 diabetes Through their effects on the hormones insulin and glucagon, GLP-1 medicines can keep blood sugar levels under control

The placebo-treated group that discontinued was 19.1 %

This is why every GLP-1 medication carries a warning against use in patients with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)